Skip to content

Comparison between the Effects of Acupuncture Relative to Other Controls on Irritable Bowel Syndrome: A Meta-Analysis

Zheng et al. · Pain Research and Management · 2019

🔍Meta-analysis of 41 RCTs👥n=3440 participants📊Moderate evidence

Evidence Level

MODERATE
72/ 100
Quality
3/5
Sample
4/5
Replication
4/5
🎯

OBJECTIVE

Evaluate the efficacy of acupuncture versus sham controls and other treatments in irritable bowel syndrome

👥

WHO

Adult patients with irritable bowel syndrome of different subtypes

⏱️

DURATION

Treatments ranged from 3 to 10 weeks

📍

POINTS

Varied — including fixed points and points individualized by syndrome differentiation

🔬 Study Design

3440participants
randomization

Acupuncture vs. sham control

n=570

8 studies comparing true with sham acupuncture

Acupuncture vs. Western medicine

n=1592

23 studies comparing acupuncture with medications

Other controls

n=1278

Comparisons with Chinese medicine, moxibustion, and tuina

⏱️ Duration: 3 to 10 weeks of treatment

📊 Results in numbers

1.22 (95% CI: 1.01-1.47)

Efficacy rate vs. sham control

1.17 (95% CI: 1.12-1.23)

Efficacy rate vs. Western medicine

I²=0-91%

Heterogeneity across studies

no significant difference

IBS symptoms vs. sham control

Percentage highlights

I²=0-91%
Heterogeneity across studies

📊 Outcome Comparison

Efficacy rate

Acupuncture vs. sham control
122
Acupuncture vs. Western medicine
117
💬 What does this mean for you?

This large review of studies showed that acupuncture may be more effective than conventional medications for irritable bowel syndrome, but did not show clear superiority over sham acupuncture. Acupuncture appears to be safe and may be a complementary option for IBS treatment.

📝

Article summary

Plain-language narrative summary

This comprehensive meta-analysis analyzed 41 randomized clinical trials involving 3,440 participants to evaluate the efficacy of acupuncture in the treatment of irritable bowel syndrome (IBS). The researchers sought to determine whether acupuncture offers real benefits compared with different types of controls. The study included both Chinese and international research, published through July 2019, representing one of the most extensive analyses of acupuncture for IBS ever conducted. The methodology followed rigorous international standards, using Chinese and Western databases to ensure comprehensive evidence retrieval.

Different types of acupuncture were analyzed, including body acupuncture, electroacupuncture, and microsystems such as auricular acupuncture. The results revealed a complex and interesting picture. When compared with sham controls (placebo acupuncture), true acupuncture showed only a small advantage in overall efficacy rate, but this advantage disappeared when more rigorous analyses were applied. However, some individual studies identified specific benefits of acupuncture for abdominal pain, discomfort, and bowel movement frequency, suggesting that there may be real biological effects related to the specificity of acupuncture points.

On the other hand, when compared with conventional Western medications, acupuncture demonstrated consistent superiority. The meta-analysis showed a 17% higher efficacy rate than conventional medicine, with low heterogeneity across studies, indicating consistent results. This beneficial effect apparently can last up to three months after treatment ends, suggesting durable benefits. The researchers also investigated the use of acupuncture as adjuvant treatment.

When combined with Western medications, Chinese medicine, or tuina, acupuncture significantly improved the efficacy of conventional treatments. This suggests that acupuncture may have particular value as complementary therapy, potentiating other treatments. As for safety, reported adverse events were minimal and mild, including only minor hematomas at the application site and one isolated case of fainting related to the needles. No serious adverse events were documented, reinforcing the favorable safety profile of acupuncture.

The clinical implications of these findings are relevant for patients and health professionals. IBS is a complex functional condition that significantly affects quality of life and represents a substantial economic burden for health systems. The fact that approximately 51% of IBS patients seek complementary medicines, with 59% specifically choosing acupuncture, demonstrates the existing demand for therapeutic alternatives.

Strengths

  • 1Large number of participants (n=3440)
  • 2Comprehensive analysis of different types of controls
  • 3Inclusion of Chinese and international studies
  • 4Reported safety assessment
  • 5Sensitivity analyses performed
⚠️

Limitations

  • 1High heterogeneity in some results
  • 2Variable methodological quality across studies
  • 3Possible expectation bias in non-blinded studies
  • 4Limitations in sham controls
  • 5Most studies conducted in China
Prof. Dr. Hong Jin Pai

Expert Commentary

Prof. Dr. Hong Jin Pai

PhD in Sciences, University of São Paulo

Clinical Relevance

Irritable bowel syndrome remains one of the most frustrating diagnoses for any clinician caring for patients with chronic pain. Pharmacological options are limited, adverse effect profiles are not always acceptable, and adherence to conventional treatment is often poor. This meta-analysis, gathering 3,440 participants in 41 clinical trials, offers a substantial evidence base for positioning acupuncture in the IBS therapeutic arsenal. The superiority of acupuncture over Western medications — with a 17% higher efficacy rate and low heterogeneity in this comparison — is the most actionable data for the clinician. Patients with mixed or alternating IBS, those intolerant to antispasmodics or who have already failed low-dose antidepressants, and those with anxiety comorbidities constitute the profile that may most clearly benefit from including acupuncture in the therapeutic plan, especially when there is overlap with gut-brain axis disorders.

Notable Findings

Two findings deserve special attention. The first is that the superiority of acupuncture over Western medicine was consistent and robust — efficacy ratio of 1.17 (95% CI: 1.12-1.23) with low heterogeneity — while the comparison with sham control revealed a statistically marginal advantage (1.22; 95% CI: 1.01-1.47) that disappeared in more rigorous analyses. This pattern is clinically revealing: it suggests that part of the acupuncture effect is non-specific, but that, compared with the available pharmacological alternatives, acupuncture delivers a real net benefit. The second notable finding is the persistence of effects for up to three months after treatment ends, which differentiates acupuncture from purely symptomatic interventions and raises the hypothesis of neuroplasticity and durable autonomic modulation as underlying mechanisms — particularly relevant for a functionally based condition such as IBS.

From My Experience

In my practice at the Pain Center of HC-FMUSP, IBS with prominent pain component is one of the indications in which I usually combine systemic acupuncture with autonomic regulation techniques — frequently combining stomach- and large-intestine-meridian points with parasympathetic-acting points such as P6 and ST36. Symptomatic response, especially in abdominal pain and discomfort, usually appears between the third and fifth session, which aligns with what this work reports in the individual studies. For stabilization, I usually work with cycles of 8 to 12 sessions, followed by monthly maintenance. I have observed that the best responders are patients with a visibly dysfunctional autonomic profile — reduced heart rate variability, fragmented sleep, associated panic syndrome — and that the combination with psychoeducation and stress regulation techniques considerably enhances the result. Patients with exclusively constipation-predominant IBS respond more heterogeneously; in these, I usually adjust the protocol with greater emphasis on points that tonify movement.

Specialist physician in Medical Acupuncture. Adjunct Professor at the Institute of Orthopedics, HC-FMUSP. Coordinator of the Acupuncture Group at the HC-FMUSP Pain Center.

Full original article

Read the full scientific study

Pain Research and Management · 2019

DOI: 10.1155/2019/2871505

Access original article

Scientific Review

Marcus Yu Bin Pai, MD, PhD

Marcus Yu Bin Pai, MD, PhD

CRM-SP: 158074 | RQE: 65523 · 65524 · 655241

PhD in Health Sciences, University of São Paulo. Board-certified in Pain Medicine, Physical Medicine and Rehabilitation, and Medical Acupuncture. Scientific review and curation of every entry in this library.

Learn more about the author →
⚕️

Medical disclaimer: This content is for educational purposes only and does not replace consultation, diagnosis, or treatment by a qualified professional. Some information may be assisted by artificial intelligence and is subject to inaccuracies. Always consult a physician.

Content reviewed by the medical team at CEIMEC — Integrated Centre for Chinese Medicine Studies, a reference in Medical Acupuncture for over 30 years.